GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (OTCPK:GIKLY) » Definitions » Loans Receivable

GIKLY (Grifols) Loans Receivable : $0 Mil (As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Grifols Loans Receivable?

Grifols's Loans Receivable for the quarter that ended in Sep. 2024 was $0 Mil.

Grifols's quarterly Loans Receivable declined from Dec. 2023 ($0.13 Mil) to Jun. 2024 ($0.11 Mil) but then stayed the same from Jun. 2024 ($0.11 Mil) to Sep. 2024 ($0.00 Mil).

Grifols's annual Loans Receivable increased from Dec. 2022 ($0.05 Mil) to Dec. 2023 ($0.13 Mil) and increased from Dec. 2023 ($0.13 Mil) to Dec. 2024 ($223.38 Mil).

Grifols Loans Receivable Historical Data

The historical data trend for Grifols's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Loans Receivable Chart

Grifols Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.04 0.05 0.13 223.38

Grifols Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.13 0.11 - 223.38

Grifols Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Grifols Loans Receivable Related Terms

Thank you for viewing the detailed overview of Grifols's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Grifols Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (OTCPK:GIKLY) » Definitions » Loans Receivable
Comparable Companies
XMAD:ROVI XMAD:ALM XMAD:FAE XMAD:RJF XMAD:LAB LLY JNJ ABBV OCSE:NOVO B XSWX:ROG LSE:AZN MRK XSWX:NOVN AMGN PFE GILD XPAR:SAN BMY LSE:GSK TSE:4519
Traded in Other Exchanges
GIFOF:USA GIFLF:USA GRFS:USA GRFe:UK GRFPe:UK 0RDV:UK 0RDU:UK GRF.P:Spain GRF:Spain G0F0:Germany G0F0:Germany OZTA:Germany OZTA:Germany GRF:Austria
Address
Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Website
https://www.grifols.com
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.